Literature DB >> 16045734

HUVECs from newborns with a strong family history of myocardial infarction overexpress adhesion molecules and react abnormally to stimulating agents.

A Paez1, A R Méndez-Cruz, E Varela, E Rodriguez, J Guevara, L Flores-Romo, L F Montaño, F A Massó.   

Abstract

Atherosclerosis is a complex disease involved in major fatal events such as myocardial infarction and stroke. It is the result of interactions between metabolic, dietetic and environmental risk factors acting on a genetic background that could result in endothelial susceptibility. Our aim was to determine the patterns of expression of adhesion molecules and whether phosphatidylserine is translocated to the cell surface of human umbilical vein endothelial cells (HUVECs) isolated from healthy newborns born to parents with a strong family history of myocardial infarction under TNF-alpha or oxLDL stimulated conditions. Compared to control HUVECs, experimental cords showed: (a) a four-fold increase in VCAM-1 expression under basal conditions, which showed no change after stimulation with the pro-atherogenic factors; (b) a two-fold increase in basal P-selectin expression that reached a 10-fold increase with any of the pro-atherogenic factors; (c) a basal ICAM-1 expression similar to P-selectin that was not modified by the pro-atherogenic molecules; (d) a similar PECAM-1 expression. Unexpectedly, phospathidylserine expression in experimental cord HUVECs was significantly increased (211 817 versus 3354 TFU) but was not associated to apoptotic death as the percentage of dead cells induced by TNF-alpha treatment was very low (0.55 versus 9.87% in control HUVECs). The latter result was corroborated by TUNEL staining. T cell adherence to HUVECs was highly up-regulated in the genetically predisposed samples. The analysis of nonpooled HUVECs, from newborns to family predisposed myocardial-infarction individuals, might represent a useful strategy to identify phenotypical and functional alterations, and hopefully, to take early preventive actions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16045734      PMCID: PMC1809470          DOI: 10.1111/j.1365-2249.2005.02858.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  46 in total

Review 1.  Phagocytosis of apoptotic cells and the resolution of inflammation.

Authors:  Paola Maderna; Catherine Godson
Journal:  Biochim Biophys Acta       Date:  2003-11-20

2.  Oxidized LDL differentially regulates MMP-1 and TIMP-1 expression in vascular endothelial cells.

Authors:  Y Huang; L Song; S Wu; F Fan; M F Lopes-Virella
Journal:  Atherosclerosis       Date:  2001-05       Impact factor: 5.162

Review 3.  Recent discoveries in assessment of coronary heart disease: impact of vascular mechanisms on development of atherosclerosis.

Authors:  R J Chilton
Journal:  J Am Osteopath Assoc       Date:  2001-09

Review 4.  Apoptosis as a determinant of atherothrombosis.

Authors:  A Tedgui; Z Mallat
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

5.  Expression of adhesion molecules by cultured human glomerular endothelial cells in response to cytokines: comparison to human umbilical vein and dermal microvascular endothelial cells.

Authors:  S Murakami; T Morioka; Y Nakagawa; Y Suzuki; M Arakawa; T Oite
Journal:  Microvasc Res       Date:  2001-11       Impact factor: 3.514

6.  The dynamic process of apoptosis analyzed by flow cytometry using Annexin-V/propidium iodide and a modified in situ end labeling technique.

Authors:  L F R Span; A H M Pennings; G Vierwinden; J B M Boezeman; R A P Raymakers; T de Witte
Journal:  Cytometry       Date:  2002-01-01

7.  Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation.

Authors:  Miguel P Soares; Mark P Seldon; Isabel Pombo Gregoire; Tatiana Vassilevskaia; Pascal O Berberat; Jia Yu; Tung-Yu Tsui; Fritz H Bach
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

8.  High insulin levels and increased low-density lipoprotein oxidizability in pediatric patients with systemic lupus erythematosus.

Authors:  Carlos Posadas-Romero; Margarita Torres-Tamayo; José Zamora-González; Blanca Estela Aguilar-Herrera; Rosalinda Posadas-Sánchez; Guillermo Cardoso-Saldaña; Guadalupe Ladrón de Guevara; Eunice Solis-Vallejo; Mohammed El Hafidi
Journal:  Arthritis Rheum       Date:  2004-01

9.  Oxidized LDL further enhances expression of adhesion molecules in Chlamydophila pneumoniae-infected endothelial cells.

Authors:  Silvana A Vielma; Marina Mironova; Ja-Ran Ku; Maria F Lopes-Virella
Journal:  J Lipid Res       Date:  2004-02-16       Impact factor: 5.922

10.  The role of the cytoskeleton in cellular adhesion molecule expression in tumor necrosis factor-stimulated endothelial cells.

Authors:  Elizabeth VandenBerg; Maria D Reid; John D Edwards; Harold W Davis
Journal:  J Cell Biochem       Date:  2004-04-01       Impact factor: 4.429

View more
  4 in total

1.  Endothelial cell invasion by Toxoplasma gondii: differences between cell types and parasite strains.

Authors:  Irma Cañedo-Solares; Montserrat Calzada-Ruiz; Luz Belinda Ortiz-Alegría; Alda Rocío Ortiz-Muñiz; Dolores Correa
Journal:  Parasitol Res       Date:  2013-06-10       Impact factor: 2.289

Review 2.  Making cell culture more physiological: a call for a more comprehensive assessment of racial disparities in endothelial cell culture studies.

Authors:  Austin T Robinson; Marc D Cook; Abbi D Lane-Cordova
Journal:  Am J Physiol Cell Physiol       Date:  2019-11-20       Impact factor: 4.249

Review 3.  Statins as Pleiotropic Modifiers of Vascular Oxidative Stress and Inflammation.

Authors:  Costas Psarros; Evangelos K Economou; Michael Koutsilieris; Charalambos Antoniades
Journal:  J Crit Care Med (Targu Mures)       Date:  2015-06-05

Review 4.  Review: in vitro microvessel models.

Authors:  Max I Bogorad; Jackson DeStefano; Johan Karlsson; Andrew D Wong; Sharon Gerecht; Peter C Searson
Journal:  Lab Chip       Date:  2015-11-21       Impact factor: 7.517

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.